레지오넬라 검사 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 최종 용도별(미생물 배양, 직접 형광 항체 염색, PCR, 기타), 지역별, 경쟁별(2020-2030년)
Legionella Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End Use (Microbial culture, Direct fluorescent antibody stain, PCR, Others), By Region & Competition, 2020-2030F
세계 레지오넬라 검사 시장은 2024년에 2억 8,425만 달러로 평가되며, 예측 기간 동안 9.39%의 CAGR로 2030년에는 4억 8,715만 달러에 달할 것으로 예상됩니다.
레지오넬라 검사 세계 시장은 레지오넬라균, 특히 레지오넬라증을 유발하는 원인균인 Legionella pneumophila(레지오넬라 뉴모필라)의 검출 및 모니터링에 사용되는 진단 검사 및 서비스 시장을 의미합니다. 레지오넬라증은 심각한 폐렴으로 냉각탑, 온수 욕조, 배관 시스템 등에서 발생하는 오염된 물방울을 흡입함으로써 감염됩니다. 질병관리본부에 따르면 2018년 한 해 동안 약 10,000건의 레지오넬라증이 보고됐습니다.
| 시장 개요 |
| 예측 기간 |
2026-2030년 |
| 시장 규모 : 2024년 |
2억 8,425만 달러 |
| 시장 규모 : 2030년 |
4억 8,715만 달러 |
| CAGR : 2025-2030년 |
9.39% |
| 급성장 부문 |
PCR 시장 |
| 최대 시장 |
아시아태평양 |
레지오넬라균은 온수 환경에서 번식하기 때문에 학교, 식당, 병원, 대규모 배관 시스템 등 물 저장에 의존하는 산업은 특히 레지오넬라균 오염에 취약합니다. 그 결과, 레지오넬라균 및 관련 감염증의 정확하고 시기적절한 진단에 대한 수요가 이들 산업 전반에 걸쳐 증가하고 있으며, 2022년 9월 아르헨티나 산 미겔 데 투쿠만에서 중증 폐렴이 발생하여 4명이 사망하고 11명이 중태에 빠지는 사건이 발생하였습니다. 이 집단 발병은 나중에 레지오넬라균, 특히 L.pneumophila균과 관련이 있는 것으로 밝혀졌습니다. 또한 2022년 6월, 뉴욕주 법무장관은 Verizon과 합의에 도달하여 Verizon이 뉴욕주 전역에서 레지오넬라증 확산을 방지하기 위해 신속하고 종합적인 조치를 취할 것을 확인했습니다.
주요 시장 촉진요인
검사 기술의 발전
주요 시장 과제
표준화된 검사 프로토콜의 부족
주요 시장 동향
신속 진단 검사
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 레지오넬라 검사 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 유형별(수질 검사, 체외진단 검사)
- 용도별(미생물 배양, 직접 형광 항체(DFA) 염색, PCR, 기타)
- 지역별
- 기업별(2024)
- 제품 시장 맵
제6장 북미의 레지오넬라 검사 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 북미 : 국가별 분석
제7장 유럽의 레지오넬라 검사 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 유럽 : 국가별 분석
제8장 아시아태평양의 레지오넬라 검사 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 아시아태평양 : 국가별 분석
제9장 남미의 레지오넬라 검사 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 남미 : 국가별 분석
제10장 중동 및 아프리카의 레지오넬라 검사 시장 전망
- 시장 규모 및 예측
- 시장 점유율과 예측
- 중동 및 아프리카 : 국가별 분석
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트
제11장 시장 역학
제12장 시장 동향과 발전
제13장 Porter's Five Forces 분석
- 업계내 경쟁
- 신규 참여의 가능성
- 공급업체의 능력
- 고객의 능력
- 대체품의 위협
제14장 경쟁 구도
- Abbott Laboratories
- Beckman Coulter, Inc.
- Bio-Rad Laboratories Inc.
- BIOMERIEUX SA
- Eiken Chemical Co., Ltd
- Hologic Inc.
- Pro-Lab PLC
- QIAGEN N.V.
- F. Hoffmann-La Roche Ltd
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
제15장 전략적 제안
제16장 조사 회사 소개 및 면책사항
ksm
Global Legionella Testing Market was valued at USD 284.25 million in 2024 and is expected to reach USD 487.15 million by 2030 with a CAGR of 9.39% during the forecast period. The Global Legionella Testing Market refers to the market for diagnostic tests and services used to detect and monitor Legionella bacteria, particularly the Legionella pneumophila species, responsible for causing Legionnaires' disease. Legionnaires' disease is a severe form of pneumonia that can be contracted through inhalation of contaminated water droplets, typically from sources like cooling towers, hot tubs, and plumbing systems. According to the Centers for Disease Control and Prevention, approximately 10,000 cases of Legionnaires' disease were reported in 2018.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 284.25 Million |
| Market Size 2030 | USD 487.15 Million |
| CAGR 2025-2030 | 9.39% |
| Fastest Growing Segment | PCR |
| Largest Market | Asia Pacific |
Legionella bacteria thrive in hot water conditions, making industries that rely on water storage, such as schools, restaurants, hospitals, and large plumbing systems, particularly susceptible to Legionella contamination. As a result, there is a growing demand across these industries for accurate and timely diagnosis of Legionella and related infections. In September 2022, an outbreak of severe pneumonia in San Miguel de Tucuman, Argentina, resulted in four deaths and 11 cases of severe illness. This outbreak was later linked to Legionella, specifically the bacterium L. pneumophila. Additionally, in June 2022, the New York Attorney General reached an agreement with Verizon to ensure the company takes swift and comprehensive action to prevent the spread of Legionnaires' disease throughout New York State.
Key Market Drivers
Advances in Testing Technologies
The Global Legionella Testing Market is experiencing substantial growth, and one of the key drivers behind this expansion is the continuous advancement of testing technologies. Legionella, a bacterium responsible for Legionnaires' disease, poses a significant public health risk. The need for rapid, sensitive, and accurate testing methods has driven innovation in the field.
Traditional methods of detecting Legionella bacteria, such as culture-based techniques, can be time-consuming and may not always yield accurate results. In contrast, modern molecular techniques, particularly Polymerase Chain Reaction (PCR), have revolutionized Legionella testing. PCR allows for the rapid and precise detection of Legionella DNA in water and environmental samples, significantly reducing the time required for diagnosis. The ability to provide quicker and more accurate results is a key factor driving the demand for Legionella testing services.
The sensitivity of testing methods is crucial when dealing with potentially harmful microorganisms like Legionella. Advances in testing technologies have led to the development of highly sensitive assays. These assays can detect even trace amounts of Legionella bacteria in various samples, including water systems, cooling towers, and air. Enhanced sensitivity ensures that potential sources of contamination are not overlooked, thereby improving the overall safety of water systems.
Automation in testing technologies has not only sped up the testing process but has also minimized the potential for human error. Automated platforms reduce the manual handling of samples, leading to greater consistency and reliability in test results. This feature is especially important in Legionella testing, where accuracy is critical for public health and safety.
Key Market Challenges
Lack of Standardized Testing Protocols
One of the primary challenges in the Legionella testing industry is the absence of standardized testing protocols. Different laboratories and testing facilities may use varying methods and equipment, leading to potential inconsistencies in results. Standardization is crucial to ensure that test results are accurate and can be reliably interpreted.
Key Market Trends
Rapid Diagnostic Tests
Rapid diagnostic tests are set to revolutionize the Legionella Testing Market. These tests offer quicker results, typically within hours, as opposed to the days required by traditional methods. Their speed and accuracy make them invaluable for timely decision-making in Legionella risk management. As demand for fast and reliable testing increases, rapid diagnostic tests will likely gain significant traction.
Key Market Players
- Abbott Laboratories
- Beckman Coulter, Inc.
- Bio-Rad Laboratories Inc.
- BIOMERIEUX SA
- Eiken Chemical Co., Ltd
- Hologic Inc.
- Pro-Lab PLC
- QIAGEN N.V.
- F. Hoffmann-La Roche Ltd
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
Report Scope:
In this report, the Global Legionella Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Legionella Testing Market, By Type:
- Water testing
- IVD testing
Legionella Testing Market, By End Use:
- Microbial culture
- Direct fluorescent antibody (DFA) stain
- PCR
- Others
Legionella Testing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Legionella Testing Market.
Available Customizations:
Global Legionella Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Legionella Testing Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Type (Water testing, IVD testing)
- 5.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
- 5.3. Product Market Map
- 5.3.1. By Type
- 5.3.2. By End Use
- 5.3.3. By Region
6. North America Legionella Testing Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Type (Water testing, IVD testing)
- 6.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
- 6.2.3. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Legionella Testing Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Type
- 6.3.1.2.2. By End Use
- 6.3.2. Canada Legionella Testing Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Type
- 6.3.2.2.2. By End Use
- 6.3.3. Mexico Legionella Testing Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Type
- 6.3.3.2.2. By End Use
7. Europe Legionella Testing Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Type (Water testing, IVD testing)
- 7.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
- 7.2.3. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Legionella Testing Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By End Use
- 7.3.2. United Kingdom Legionella Testing Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By End Use
- 7.3.3. France Legionella Testing Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By End Use
- 7.3.4. Italy Legionella Testing Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Type
- 7.3.4.2.2. By End Use
- 7.3.5. Spain Legionella Testing Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Type
- 7.3.5.2.2. By End Use
8. Asia-Pacific Legionella Testing Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Type (Water testing, IVD testing)
- 8.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
- 8.2.3. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Legionella Testing Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By End Use
- 8.3.2. Japan Legionella Testing Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By End Use
- 8.3.3. India Legionella Testing Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By End Use
- 8.3.4. Australia Legionella Testing Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By End Use
- 8.3.5. South Korea Legionella Testing Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By End Use
9. South America Legionella Testing Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Type (Water testing, IVD testing)
- 9.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
- 9.2.3. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Legionella Testing Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By End Use
- 9.3.2. Argentina Legionella Testing Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By End Use
- 9.3.3. Colombia Legionella Testing Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By End Use
10. Middle East and Africa Legionella Testing Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Type (Water testing, IVD testing)
- 10.2.2. By End Use (Microbial culture, Direct fluorescent antibody (DFA) stain, PCR, Others)
- 10.2.3. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Legionella Testing Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By End Use
- 10.3.2. Saudi Arabia Legionella Testing Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By End Use
- 10.3.3. UAE Legionella Testing Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By End Use
- 10.3.4. Kuwait Legionella Testing Market Outlook
- 10.3.4.1. Market Size & Forecast
- 10.3.4.2. Market Share & Forecast
- 10.3.4.2.1. By Type
- 10.3.4.2.2. By End Use
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Recent Development
- 12.2. Mergers & Acquisitions
- 12.3. Product Launches
13. Porter's Five Forces Analysis
- 13.1. Competition in the Industry
- 13.2. Potential of New Entrants
- 13.3. Power of Suppliers
- 13.4. Power of Customers
- 13.5. Threat of Substitute Products
14. Competitive Landscape
- 14.1. Abbott Laboratories
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Recent Developments
- 14.1.5. Financials (As Reported)
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
- 14.2. Beckman Coulter, Inc.
- 14.3. Bio-Rad Laboratories Inc.
- 14.4. BIOMERIEUX SA
- 14.5. Eiken Chemical Co., Ltd
- 14.6. Hologic Inc.
- 14.7. Pro-Lab PLC
- 14.8. QIAGEN N.V.
- 14.9. F. Hoffmann-La Roche Ltd
- 14.10. Takara Bio Inc.
- 14.11. Thermo Fisher Scientific Inc.
15. Strategic Recommendations
16. About Us & Disclaimer
